Bcl-xL-inhibitory BH3 mimetics (ABT-737 or ABT-263) and the modulation of cytosolic calcium flux and platelet function.
Simone M
SM
Schoenwaelder
Shaun P
SP
Jackson
D000814:Aniline Compounds / Q000494:pharmacology*; D017209:Apoptosis / Q000187:drug effects*; D001792:Blood Platelets / Q000187:drug effects*; D020013:Calcium Signaling / Q000187:drug effects*; D006801:Humans; D015539:Platelet Activation / Q000187:drug effects*; D010975:Platelet Aggregation Inhibitors / Q000494:pharmacology*; D013449:Sulfonamides / Q000494:pharmacology*; D051020:bcl-X Protein / Q000037:antagonists & inhibitors*
D000814:Aniline Compounds; D010975:Platelet Aggregation Inhibitors; D013449:Sulfonamides; D051020:bcl-X Protein